Use of inhibin B in recurrent ovarian granulosa cell tumors

Cover Page

Cite item

Full Text

Abstract

Early diagnosis of recurrent ovarian granulose cell tumors (OGCT) remains an urgent problem of modern oncogynecology. Inhibin B is one of the most potentially important markers of OGCT. Nevertheless, in the world there are today only single studies evaluating the clinical value of inhibin B. The paper presents serum inhibin B measurements in patients with recurrent OGCT. The findings suggest that inhibin B has a high (80-100%) diagnostic sensitivity and 100% specificity.

About the authors

A. M. Beishembayev

Department of Oncology, Russian State Medical University, Russian Agency for Health Care

Author for correspondence.
Email: almazyaka@yandex.ru
Russian Federation

N. V. Lyubimova

N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow

Russian Federation

V. M. Abayev

N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow

Russian Federation

K. I. Zhordania

N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences, Moscow

Russian Federation

V. A. Khailenko

Department of Oncology, Russian State Medical University, Russian Agency for Health Care

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36991 от  21.07.2009.